Clinical Research Site Infrastructure and Efficiency-Reference-Cited by-同舟云学术

Clinical Research Site Infrastructure and Efficiency

Published:2010-09 Issue:5 Volume:6 Page:249-252
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Baer Allison R.¹,Bridges Kerry Dune¹,O'Dwyer Mary¹,Ostroff Joy¹,Yasko Joyce¹

Affiliation:

1. American Society of Clinical Oncology, Alexandria, VA; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Roswell Park Cancer Institute, Buffalo, NY

Abstract

Increasing efficiency in the clinical trials development process ensures a vibrant clinical trials system that makes best use of resources, and keeps pace with scientific discoveries in the field of cancer research.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.000109

Reference5 articles.

1. Impact of trial development time on accruals at CCOPs: The case of the MARVEL trial.

2. Early indicators of accrual success: Time-to-first-patient and accrual performance at an anticipated enrollment milestone-A study of NCI-CTEP-sponsored clinical trials.

3. Clinical trial metrics: Protocol performance and resource utilization from 14 cancer centers

4. Protocol performance metrics and resource utilization of phase II investigator-initiated trials.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is this study feasible? Facilitating management of pragmatic trial planning milestones under a phased award funding mechanism;Trials;2019-05-30

2. ReCAP: Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community;Journal of Oncology Practice;2016-01

3. Impact of NCI-Mandated Scientific Review on Protocol Development and Content;Journal of the National Comprehensive Cancer Network;2015-04

4. Growing risk avoidance in Asian oncology site selection: how trends in site selection are limiting growth of the Asia cancer trial landscape;Open Access Journal of Clinical Trials;2013-12